TELMIPRAZ – LN

Category: Antihypertensive Combination
Composition: Telmisartan 40 mg + Cilnidipine 10 mg
Overview
Combination therapy for patients requiring two complementary antihypertensive agents.

Mechanism of Action
Telmisartan blocks AT1 receptors while Cilnidipine inhibits L- and N-type calcium channels.

Key Clinical Uses
• Dual mechanism for blood pressure control.
• Supports vascular protection.
• Once-daily dosing.

Dosage Form: Tablet

Storage
Store below 30°C in a cool, dry place. Protect from moisture and keep out of reach of children.

Disclaimer
For use by registered medical practitioners only. Prescribe according to the approved prescribing information.